Ironwood Pharmaceuticals to Present at 2016 RBC Capital Markets Global Healthcare Conference

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Ironwood Pharmaceuticals to Present at 2016 RBC Capital Markets Global Healthcare Conference

Mizuho Securities Reiterates Buy Following Ironwood Pharma's (IRWD) Strong 4Q Results

February 19, 2016 9:30 AM EST

Mizuho Securities reiterated a Buy rating and $15.00 price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) following the company's 4Q earnings report. IRWD reported revenues of $53.3M, beating consensus estimates of $44.5M. EPS loss of ($0.09) also came in ahead of consensus' ($0.17). Management also issued... More

Leerink Partners Remains Sidelined After Ironwood Pharma's (IRWD) 4Q

February 19, 2016 7:22 AM EST

Leerink Partners reiterated a Market Perform rating on Ironwood Pharmaceuticals (NASDAQ: IRWD), and cut the price target to $11.00 (from $12.00), following the company's 4Q earnings release. IRWD reported 4Q Linzess sales of ~$130m, coming in slightly below Leerink's estimate of ~$131m. Collaborative revenues of ~$53m were in line with estimates. IRWD plans to progress IW-1701 and IW-1973 into... More